Phase I Study of AT13148, a Novel AGC Kinase Inhibitor

Clinical trial NCT01585701 · COMPLETED

Trial details

NCT number: NCT01585701
Sponsor: Cancer Research UK
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours

Start date: 2012-05-01
Primary completion: 2018-01-10
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.